BridgeBio Oncology Therapeutics, Inc. Shareholders' Equity
BridgeBio Oncology Therapeutics, Inc. (BBOT) had Shareholders' Equity of $323.11 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-11
- 2026-06-30: Stockholders' Equity Attributable to Parent $323.11M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $372.28M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $411.10M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $446.70M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $323.11M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $372.28M 10-Q · filed 2026-08-11 | |
| 2025-12-31 | $411.10M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $446.70M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | -$227.73M 10-Q · filed 2026-08-11 | -$7.27M 10-Q · filed 2025-08-01 |
| 2025-03-31 | -$200.03M 10-Q · filed 2026-08-11 | -$6.15M 10-Q · filed 2025-05-15 |
| 2024-12-31 | -$178.64M 10-Q · filed 2026-08-11 | -$3.73M 10-K · filed 2025-03-11 |
| 2024-09-30 | -$159.21M 10-Q · filed 2025-11-12 | -$3.52M 10-Q · filed 2024-11-14 |
| 2024-06-30 | -$143.44M 10-Q · filed 2025-11-12 | -$3.37M 10-Q · filed 2024-08-14 |
| 2024-03-31 | -$128.87M 10-Q · filed 2025-11-12 | -$3.22M 10-Q · filed 2024-05-15 |
| 2023-12-31 | -$115.64M POS AM · filed 2026-04-30 | -$63.57K 10-Q · filed 2024-05-15 |
| 2023-09-30 | -$21.88K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | -$21.88K 10-Q · filed 2024-11-14 | |
| 2023-03-31 | -$21.88K 10-Q · filed 2024-11-14 | |
| 2022-12-31 | -$21.88K 10-K · filed 2025-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |